Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy.

Modjtahedi, Helmout, Moscatello, David K., Box, Gary, Green, Margaret, Shotton, Christine, Lamb, David J., Reynolds, Lesley J., Wong, Albert J., Dean, Christopher, Thomas, Hilary and Eccles, Suzanne (2003) Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy. International Journal of Cancer, 105(2), pp. 273-280. ISSN (print) 0020-7136

Full text not available from this archive.
Item Type: Article
Uncontrolled Keywords: EGFR, EGFRvIII, monoclonal antibody therapy, ADCC, metastasis
Research Area: Allied health professions and studies
Faculty, School or Research Centre: Faculty of Science (until 2011) > School of Life Sciences
Depositing User: David Salliss
Date Deposited: 26 Nov 2007
Last Modified: 01 Jun 2009 21:43
URI: http://eprints.kingston.ac.uk/id/eprint/2023

Actions (Repository Editors)

Item Control Page Item Control Page